Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSingapore General Hospital

About this trial

The purpose of this study is to identify factors that predict the development of decompensation, acute-on-chronic liver failure (ACLF) and death in patients with liver cirrhosis. Clinical data will be retrieved from existing hospital records. This information may help doctors to identify patients with cirrhosis who are at risk of deterioration earlier (before they develop complications) and to develop effective treatment strategies to prevent or delay these complications.

This study is designed as a prospective, non-interventional, observational study. This means that if you agree to participate in the study, you will not be required to undergo any additional hospital visits, tests, procedures or interventions other than the usual standard-of-care management that your doctor will provide. If you consent to participate in this study, you will be providing the study investigators permission to review and analyse your clinical data from the hospital clinical records. Your data will be collected throughout the course of your disease until liver transplantation or death.

Eligibility criteria

Qualifiers

Patients with clinical diagnosis of liver cirrhosis

Age 18 years and above (parental consent required if below 21 years)

Willing and able to provide informed consent

Disqualifiers

No clinical evidence of liver cirrhosis

Not willing to provide informed consent

Trial design

Treatments tested in this trial

  • Observation

Treatment groups

2,200 Participants
are divided into 1 treatment group

Sponsors and collaborators